Related Experiment Video
Updated: May 23, 2026
09:52
A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
Caveolin-1, caveolae, and glioblastoma
Marie-Odile Parat1, Gregory J Riggins
1University of Queensland School of Pharmacy, PACE, 20 Cornwall St., Woollloongabba QLD 4102, Australia. m.parat@uq.edu.au
Neuro-Oncology
|April 18, 2012
Summary
Caveolin-1 and caveolae are present in glioblastoma cells, influencing tumor growth and invasiveness. Targeting caveolin-1 may offer new therapeutic strategies for glioblastoma multiforme (GBM).
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis and limited treatment options.
- Caveolae, specialized plasma membrane domains, and their main protein, caveolin-1, are found in GBM cells.
- Caveolin-1's role in cancer is context-dependent, acting as either a tumor suppressor or oncogene.
Purpose of the Study:
- To review the expression and function of caveolin-1 and caveolae in GBM.
- To analyze their role in GBM cellular signaling, growth, and invasiveness.
- To evaluate caveolin-1 as a potential therapeutic target for GBM.
Main Methods:
- Review of existing literature on caveolin-1, caveolae, and GBM.
- Analysis of biochemical and morphological data regarding GBM cells.
- Examination of studies on cellular signaling, growth, and invasiveness pathways in GBM.
Main Results:
- Caveolae and caveolin-1 are present and functional in glioblastoma cells.
- Caveolin-1 plays a significant role in regulating GBM cellular signaling, growth, and invasiveness.
- The dual role of caveolin-1 as a tumor suppressor or oncogene is observed in GBM.
Conclusions:
- Caveolin-1 and caveolae are integral to GBM biology.
- Targeting caveolin-1 presents a promising therapeutic avenue for glioblastoma treatment.
- Further research is warranted to fully elucidate caveolin-1's therapeutic potential in GBM.
Related Concept Videos
01:38Intralumenal Vesicles and Multivesicular Bodies
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
01:12Clathrin Coated Vesicles
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
01:45Vesicular Tubular Clusters
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
With the help of motor proteins such...
00:59COP Coated Vesicles
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...
01:33Overview of Secretory Vesicles
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
01:12Golgi Matrix Proteins
Golgi matrix proteins are a group of highly dynamic proteins that maintain the stacked structure of Golgi. These proteins adapt to rapid morphological changes of the Golgi during the cell cycle. During cell division, mild proteolysis removes these connections resulting in Golgi unstacking. In The daughter cells, these proteins help reassemble the unstacked Golgi.
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...